Bryn Inc. undergoes change in control; MEDO Healthcare acquires 84.7% voting power, new CEO appointed

Byrn, Inc.

On April 24, 2026, MEDO Healthcare LLC purchased 10M shares of Series A-1 Preferred Stock for $175,000 cash, gaining 84.7% voting power.
David Lazar resigned as sole officer/director; John Leo appointed as sole director and CEO, Arthur Magee as CFO and Secretary.
John Leo holds 27.4% membership interest in MEDO Healthcare and also owns Primary Capital LLC.
New management team has extensive investment banking and capital markets experience.

item 5.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Lazar

Sole Officer and Director

BRRN · Byrn, Inc.

Effective: 2026-04-24
Successor: John Leo
Filed: May 11, 2026, 4:01 PM ET

Mr. Lazar resigned on April 24, 2026 from his positions as sole officer and director of the Registrant.

Appointed

Arthur Magee

Chief Financial Officer and Secretary

BRRN · Byrn, Inc.

Effective: 2026-04-24
Filed: May 11, 2026, 4:01 PM ET

Mr. Lazar also appointed Arthur Magee, an affiliate of John Leo, to serve upon Mr. Lazar’s resignation as CFO and Secretary of the Registrant.

Appointed

John Leo

Sole Director and Chief Executive Officer

BRRN · Byrn, Inc.

Effective: 2026-04-24
Filed: May 11, 2026, 4:01 PM ET

Mr. Lazar appointed John Leo to serve upon Mr. Lazar’s resignation as sole director and CEO of the Registrant.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

David Lazar resigned as Sole Officer and Director at Byrn, Inc..

Action: resigned
Role: Sole Officer and Director

Exact text from the filing

Mr. Lazar resigned on April 24, 2026 from his positions as sole officer and director of the Registrant.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Arthur Magee was appointed as Chief Financial Officer and Secretary at Byrn, Inc..

Action: appointed
Role: Chief Financial Officer and Secretary

Exact text from the filing

Mr. Lazar also appointed Arthur Magee, an affiliate of John Leo, to serve upon Mr. Lazar’s resignation as CFO and Secretary of the Registrant.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

John Leo was appointed as Sole Director and Chief Executive Officer at Byrn, Inc..

Action: appointed
Role: Sole Director and Chief Executive Officer

Exact text from the filing

Mr. Lazar appointed John Leo to serve upon Mr. Lazar’s resignation as sole director and CEO of the Registrant.

View on SEC.gov

Byrn, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-054461

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.